Healthcare

Saluda Medical, Inc. (ASX:SLD) has released its Q1 FY27 update, reporting strong revenue growth led by its US business. The medical device company, which develops spinal cord stimulation technology for chronic pain, also reaffirmed its FY27 guidance and provided updates on its product pipeline.

The company expects FY27 revenue growth of 4.0% to 6.0% and an operating EBITDA margin of 19.5% to 20.5%. It also maintained capital expenditure guidance of A$50 million to A$60 million. Guidance represents the company’s stated expectations rather than an achieved result, with the …

Control Bionics (ASX:CBL) recorded $999k in customer receipts for the September quarter, described as broadly unchanged from the preceding quarter. The company reported unaudited monthly revenue growth throughout the period, although it did not disclose a quarterly revenue figure. Operating cash outflow was $2.75m, …

Star Combo Pharma Limited (ASX:S66) operates within the health and wellness market and reported results and operating developments across its latest disclosure period.. The 29 October 2026 market quotation for S66 was A$0.14, with a daily change of unchanged. FY26 revenue from ordinary activities …

Holista Colltech Limited (ASX:HCT) operates within the health and wellness market and reported results and operating developments across its latest disclosure period.. As of 29 October 2026, HCT shares were priced at A$0.037, unchanged on the day. H1 FY26 revenue grew 3.6% to A$2.99 …

Skin Elements executed an exclusive distribution agreement with Farmlands Co-Operative Society following product trials in New Zealand’s kiwifruit industry. The initial order for ECO-Nurture was valued at NZD 600,000 before New Zealand GST. A first delivery valued at NZD 150,000 was completed during the …

EVE Health Group progressed its Libbo pilot bioequivalence program during the June 2026 quarter. Libbo is a 10-milligram oral-soluble film containing vardenafil. The company finalised the pilot-study protocol and engaged a contract research organisation and clinical site. The pilot was designed to compare Libbo …